Evidence map›Paper›PMID 41329430›Full record

ArticleClinical rheumatology2026

Evaluation of kinesiophobia, central sensitization, and related factors in patients with gout: a cross-sectional study.

Kübra Tuncer, Erkan Kozanoğlu, Aylin Sariyildiz, Ayşegül Yetişir

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kübra TuncerDepartment of Physical Medicine and Rehabilitation, Faculty of Medicine, Cukurova University, Adana, Türkiye. kubtuncer@gmail.com.ORCID https://orcid.org/0009-0006-8677-7655
Erkan KozanoğluDepartment of Physical Medicine and Rehabilitation, Faculty of Medicine, Cukurova University, Adana, Türkiye.ORCID http://orcid.org/0000-0002-0167-3384
Aylin SariyildizDepartment of Physical Medicine and Rehabilitation, Faculty of Medicine, Cukurova University, Adana, Türkiye.ORCID http://orcid.org/0000-0002-8835-4203
Ayşegül YetişirDivision of Rheumatology, Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Cukurova University, Adana, Türkiye.ORCID http://orcid.org/0000-0001-7070-3076

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo determine the prevalence of kinesiophobia and central sensitization and the association of kinesiophobia and central sensitization with clinical variables in patients with gout.

methodThis cross-sectional study included patients with gout and age- and gender-matched individuals. All participants were assessed by using the Tampa Scale of Kinesiophobia (TSK), Central Sensitization Inventory (CSI), Medical Outcomes Study 36-Item Short Form Health Survey (SF-36), Hospital Anxiety and Depression Scale (HADS), and International Physical Activity Questionnaire-Short Form (IPAQ-SF). Disease-related clinical variables, Gout Activity Score (GAS), and Health Assessment Questionnaire-Disability Index (HAQ-DI) were also recorded.

resultsThe frequency of kinesiophobia and central sensitization in patients with gout was 62.3% and 33.8%, respectively. TSK, CSI, and HADS scores were higher, and SF-36 and IPAQ-SF scores were lower in patients with gout than in controls. Patients with kinesiophobia statistically had higher GAS, CSI, HADS, and HAQ-DI scores and lower subscores of SF-36 (except emotional role) and total IPAQ-SF scores than the non-kinesiophobia group. GAS, TSK, HADS, and HAQ-DI scores were found to be higher, and SF-36 and total IPAQ-SF scores were lower in patients with central sensitization compared to those without central sensitization. TSK and CSI scores had significant positive correlations with each other (ρ = 0.650) and with pain, GAS, HADS-D, HADS-A, and HAQ-DI scores (ρ ranged from 0.414 to 0.702). According to the regression analyses, the CSI score appeared to determine the severity of kinesiophobia.

conclusionsKinesiophobia and central sensitization frequently accompany patients with gout. These were associated with increased pain intensity, decreased quality of life, impaired emotional health, functionality, and physical activity. Key Points • The frequency of central sensitization and kinesiophobia accompanying patients with gout is considerable. • Mental health plays a fundamental role in influencing  central sensitization in gout. • Central sensitization was independently associated with kinesiophobia. • These close associations lead to challenges in optimizing management, functionality, physical activity level, and quality of life in gout.

Indexed as

Central Nervous System SensitizationGoutPhobic DisordersAdultAgedCross-Sectional StudiesDisability EvaluationExerciseFemaleHumansKinesiophobiaMaleMiddle AgedPrevalenceQuality of LifeSurveys and QuestionnairesCentral sensitizationEmotional healthGoutKinesiophobiaPhysical activityQuality of life

Identifiers

PMID41329430

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.